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Abstract. Investigating the causes of failure of Fontan circulation in
individual patients remains challenging despite detailed combined inva-
sive cardiac catheterisation and magnetic resonance (XMR) exams at
rest and during stress. In this work, we use a biomechanical model of
the heart and Fontan circulation with the components of systemic and
pulmonary beds to augment the diagnostic assessment of the patients
undergoing the XMR stress exam. We apply our model in 3 Fontan pa-
tients and one biventricular “control” case. In all subjects, we obtained
important biophysical factors of cardiovascular physiology – contractil-
ity, contractile reserve and changes in systemic and pulmonary vascular
resistance – which contribute to explaining the mechanism of failure in
individual patients. Finally, we used the patient-specific model of one
Fontan patient to investigate the impact of changes in pulmonary vas-
cular resistance, aiming at in silico testing of pulmonary vasodilation
treatments.
Keywords: Fontan circulation · heart failure · dobutamine stress · pul-
monary vascular resistance · pulmonary vasodilation therapy.
1 Introduction
Patients with Fontan circulation – a surgically established circulation for pa-
tients with a single functional ventricle in which the systemic and pulmonary
circulations are coupled in series – experience a progressive decline in cardio-
vascular function, ultimately leading to heart failure [6]. Fontan failure (FF) is
multifactorial and often involves both the heart and the circulation, e.g. a re-
duced myocardial contractility, contractile reserve, or an increased pulmonary
vascular resistance (PVR). Identifying the exact cause of failure is therefore dif-
ficult. A potential treatment option for FF is pulmonary vasodilation (PVD) [4].
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However, its efficacy remains inconclusive, especially in patients without elevated
PVR. Several specialised centres use combined cardiac MRI and catheterisation
(XMR) at rest and during pharmacological stress to investigate the causes of
FF, and to identify patients that might benefit from PVD [9]. These diagnostic
exams generate rich datasets of combined ventricular and pulmonary pressures,
blood flow and cardiac function. Despite this, understanding the role of each pa-
rameter in FF in individual patients remains challenging. We hypothesise that
biomechanical modelling may improve the interpretation of XMR exams, and the
augmented knowledge of patients’ physiology could be considered in the PVD
reactivity testing to possibly reduce its invasiveness.
In this work we build patient-specific models of the Fontan circulation (heart
with systemic and pulmonary circulations in series) based on the stress XMR
exam, which can provide the values of myocardial contractility, SVR and PVR
at rest and their changes during stress. Then, using such an “avatar” of rest and
stress physiology from one patient, we investigate the impact of an increased
and decreased PVR on the heart and circulation – the changes known to take
place with aging and after PVD, respectively.
2 Methods
2.1 Data
Three patients with Fontan circulation (underlying diagnosis: hypoplastic left
heart syndrome) and early-stage FF underwent an XMR dobutamine stress
exam. During the exam, cine MRI, phase-contrast flow through aorta and branch
pulmonary arteries (PAs), together with catheter pressure measurements in the
aorta, systemic ventricle and PAs were obtained at rest and during pharmaco-
logical stress (infusion of dobutamine 10 µg/kg/min), see Fig. 1. None of the
patients had significant collateral flow or fenestration shunts. In addition to the
single-ventricular patients, one patient with a biventricular heart was included
in the study. This patient suffered from billiary atresia and underwent a stress
XMR during work-up for liver transplantation. This study was approved by our
regional ethics committee, London UK (Ethics Number 09H0804062) and writ-
ten informed consent was obtained for all subjects.
2.2 Model
The systemic ventricle is modelled using the multiscale biomechanical model de-
scribed in [3], of which the geometry and kinematics were reduced to a sphere [2],
while all other biophysical properties correspond to the full 3D model. Briefly,
the passive part of the myocardium is modelled using the hyperelastic potential
by Holzapfel & Ogden [5], and the active component by a system of ordinary dif-
ferential equations representing chemically controlled actin-myosin interactions
generating active stress, of which the asymptotic value σ0 is directly related to
myocardial contractility.
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Fig. 1. Data of a selected Fontan patient acquired at rest and during stress.
The ventricle is connected to the circulation system, represented by a 3-stage
Windkessel (WK) model consisting of the very proximal part of the circulation
(aorta and large arterial branches with resistance and capacitance Rprox and
Cprox); main part of the systemic circulation (Rsyst, Csyst); and the pulmonary
circulation (Rpulm, Cpulm), see Fig. 2. The role of the proximal element is to
capture the correct peak aortic pressure. Its effect on the overall ventricular
afterload is limited, asRprox and Cprox are∼ 1/10 of their systemic counterparts.
Therefore, we associate systemic vascular resistance (SVR) directly with Rsyst,
while Rpulm represents PVR.
Paorta Pdist PPA
Pve
EDP
Cprox Csyst Cpulm
Rprox Rsyst Rpulm
Ventricle
Myocardium
Q
Fig. 2. Scheme of the model of systemic ventricle with the corresponding circulation:
2-stage Windkessel model for biventricular subject (terminating by central venous pres-
sure Pve); 3-stage Windkessel with the pulmonary component in blue (PPA being pul-
monary artery pressure, and ending by the end-diastolic ventricular pressure EDP).
In the biventricular case, only a 2-stage WK model was used (without the
pulmonary part). For the Fontan patients, in addition to the 3-stage WK, a
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circulation with SVR and PVR lumped into “total vascular resistance” (TVR)
was calibrated. The role of these 2-stage WK models was to obtain a simpler
representation of the afterload against which the systemic ventricle works.
The heart and circulation models where simulated using the MATLAB-based
simulator CardiacLab developed at Inria in the team MΞDISIM (main contrib-
utor Philippe Moireau).
2.3 Model calibration
The 3-stage WK model was calibrated sequentially – first the systemic, followed
by the pulmonary part. The systemic and pulmonary resistances were initialised
using the mean difference of respective pressures (mean aortic, pulmonary artery
or terminal end-diastolic ventricular) and cardiac output (CO), as Ri ∼ ∆PiCO .
The associated capacitances were pre-calibrated by assuming the time constants
(given by multiplication of resistance and capacitance) being 1 second. For a
detailed calibration, the measured aortic flow was imposed into the circulatory
model firstly with the terminal pressure being the pulmonary artery pressure in
the regime of a 2-stage (proximal+systemic) WK to calibrate the systemic part;
then, the proximal resistance was adjusted to match the peak aortic pressure;
lastly, the ventricular EDP was used as the terminal pressure in the 3-stage WK
to calibrate the pulmonary part. For the biventricular “control” case (and to
obtain TVR, the lumped SVR and PVR, in Fontan patients), the 2-stage WK
was calibrated (i.e. steps 1 and 2 above). The calibration process was performed
at rest and during stress.
The heart model was calibrated using the following sequence: First, the ge-
ometrical relations in the heart model (ventricular volume and wall thickness)
were prescribed using the end-diastolic volume (EDV) and myocardial wall mass
obtained from cine MRI. The volume of unloaded ventricle V0 was assumed to be
50% of EDV [7]. The passive properties of the heart were adjusted by imposing
the measured EDP and subsequently multiplying the hyperelastic potential by
a “relative stiffness parameter” to obtain the measured EDV. Next, the active
properties of the ventricle were adjusted by connecting the calibrated circulation
WK model, imposing the timing of the activation (according to the measured
ECG), and adjusting the myocardial contractility σ0 to reach the end-systolic
volume (ESV) and aortic flow as in the data. After this calibration at rest, the
adjustments in the model during stress were obtained by connecting the WK
calibrated using the stress data, adjusting the electrical activation according to
the observed chronotropic effect, prescribing the preload pressure according to
data, and lastly adjusting σ0 to match the observed end-systolic volume (ESV)
and aortic flow.
2.4 In silico PVD testing
Using the heart-circulation model of a selected Fontan patient, calibrated at rest
and stress, we performed an in silico study to investigate the impact of modifying
the PVR on pulmonary artery pressure (invasive indicator) and on stroke volume
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(SV, non-invasive indicator). The model was run with varying PVR (by factors
0.25, 0.5, 2 and 4), while keeping all other parameters as calibrated for rest /
stress). We evaluated the changes in SV and PA pressure in comparison to those
in our original calibration.
Patient contractility contractility SVR SVR PVR PVR TVR TVR
rest σrest0 stress rest R
rest
syst stress rest R
rest
pulm stress rest stress
(kPa) (×σrest0 ) (MPa·sm3 ) (× rest) (MPa·sm3 ) (× rest) (MPa·sm3 )
FP 1 65 2.4× 98 1.22× 11 0.91× 100 1.25×
FP 3 73 2.1× 108 1.62× 9 1.48 × 125 1.48×
FP 5 73 2.0× 171 1.22× 19 0.76× 190 1.17×
CC 1 70 1.4× 130 0.90× N/A N/A N/A N/A
Table 1. Summary of the changes in contractility, systemic and pulmonary vascular
resistances (SVR, PVR) and total pulmonary resistance (TVR) for Fontan patients
(FP) and biventricular control case (CC) during dobutamine stress.
3 Results
3.1 Patient-specific heart-circulation models at rest and stress
The quantitative values of parameters of the circulation and myocardial contrac-
tility are shown in Table 1. Fig. 3 shows the simulated indicators compared with
the data for a selected Fontan patient at rest and during stress. Fig. 4 compares
the systemic and pulmonary vascular resistances for all patients at rest and their
adaptation during stress.
3.2 In silico test of PVD at various physiology stages
Fig. 5 shows the assumed effect of PVD in Fontan patient 5. The blue marker
represents the PVR value obtained from the original calibrations. The mean
pulmonary pressures were similar at rest and during stress. SV was higher at
rest, compared to stress. With varying PVR, there was a significant change in SV
at rest, see Fig. 5. This trend was much less pronounced during stress. Varying
PVR did also result in a significant and expected change in average pulmonary
pressures, both at rest and during stress.
4 Discussion
In this study, we explored the use of biomechanical models to investigate fac-
tors underlying heart failure in patients with Fontan circulation. We used XMR
datasets obtained at rest and during stress to create patient-specific models to
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Fig. 3. Simulations at rest (black) and during stress (red) for Fontan patient 5.
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Fig. 4. Systemic and pulmonary vascular resistances at rest (black) and stress (red) in
all Fontan patients (FP) and the control biventricular case (CC).
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Fig. 5. Stroke volume (left) and mean pulmonary pressure (right) response to varying
PVR in Fontan patient 5. The blue marker represents the original patient-specific
calibrations.
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access the biophysical parameters that are not directly available from the data
themselves. Good calibrations were obtained for all included cases at rest and
during stress: the data-simulation error of maximum ventricular pressure av-
eraged over all subjects and physiological states was 4.7 mmHg; error of mean
pulmonary pressure 0.25 mmHg; and error of stroke volume 1.2 mL, see example
Fig. 3. This suggests that our proposed model, while simplifying both the heart
and circulation, can well describe the different physiological conditions. With
such close-to-real-time running models (computation time of one cardiac cycle
being ∼10 seconds on a standard laptop), we were able to obtain fast simulations
using standard computers within a clinically relevant time-frame (i.e. compatible
with ∼3-hour time-frame to clinically evaluate and report the outcomes of the
exam).
At rest, myocardial contractility was slightly increased in Fontan patients
compared to the biventricular case. However, all Fontan patients had a good
contractile reserve (> 2× resting values) [1], see Table 1. These results suggest
that FF in these particular Fontan patients was not due to systolic dysfunction.
Our coupled model also allowed to investigate the vascular response. At rest,
we did not see significant differences in resistance between Fontan patients and
the control case. However, during stress the vascular adaptations varied. In the
control case, the resistance decreased – an expected response in normal phys-
iology [10]. However, in our Fontan patients the total resistance of the system
(TVR) increased. By looking at the changes in resistance of the two in-series-
coupled beds (i.e. SVR and PVR), we could see that SVR was the main contrib-
utor to the effect, while there was only a relatively small change in PVR. This
could reflect a vascular maladaptation of the systemic circulation to the chronic
high systemic venous pressures [11] – the result of the circulations coupled in
series.
While PVR is only a relatively small component of TVR, clinical and exper-
imental studies have shown that it might have a large impact on cardiac output
in the Fontan circulation [11]. This has formed the rationale behind PVD treat-
ment. However, whether all patients benefit from PVD is unclear, especially
when PVR is not elevated. We used our calibrated model in Fontan patient 5 to
investigate the impact of hypothetical changes in PVR in silico, while keeping
all other factors of the model as calibrated for rest and at stress (preload, heart
rate, contractility and SVR). The model at rest suggests that varying PVR could
result in a significant shift in stroke volume – i.e. a non-invasive index – despite
the fact that the PVR was not significantly elevated in this patient [8].
The main limitation of our preliminary in silico PVD test is that preload
was fixed while varying PVR, even though a change in PVR is likely to result
in a change in flow towards the heart [8]. We aim to address this limitation
by exploiting closed-loop heart-circulation models, once having data obtained
during XMR exams that include in vivo PVD provocation both at rest and
during stress. The approach nevertheless represents an initial step in studying
some non-invasive indices, which might contribute to the assessment of PVD in
individual patients.
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Finally, we aim to further refine the circulatory model to include potential
pathological systemic-to-venous or veno-venous shunts, which are often formed
in Fontan patients, even though these were not present in our subjects.
5 Conclusion
In this paper, we showed that our models allow a detailed investigation of some
key biophysical factors of the pathological stress response in Fontan patients.
Moreover, we performed first steps in exploring the use of modelling to exam-
ine potential changes in PVR on the cardiovascular system. We aim to further
investigate modelling in a larger group of patients, loop our models to include
venous return and subsequently compare the results of in silico PVD experi-
ments to data of prospectively examined patients. Ultimately, we hope to obtain
the models that would contribute into the identification of patients who could
benefit from PVD, in order to decrease the invasiveness of PVD-reactivity tests.
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